Dr. Reddy's debuts Tecfidera generic

Press enter to search
Close search
Open Menu

Dr. Reddy's debuts Tecfidera generic

By Sandra Levy - 09/29/2020

Dr. Reddy’s is releasing a new generic.

The company's newest offering is dimethyl fumarate delayed-release capsules, a generic of Biogen’s Tecfidera.

The Tecfidera brand and generic had a market value of approximately $3.8 billion for the most recent 12 months ended June 2020, according to IQVIA.

Dr. Reddy’s generic Tecfidera is available in 120-mg and 240-mg capsules in bottle count sizes of 14 and 60 capsules, respectively.

Related Topics